AOD-9604 for Weight Management

AOD-9604 is a peptide fragment derived from human growth hormone (HGH) that has been studied for its potential role in fat metabolism. Unlike HGH, AOD-9604 does not affect blood sugar or IGF-1 levels, making it a safer alternative for weight management support.

How it works:
AOD-9604 helps stimulate the breakdown of stored fat and prevents the formation of new fat cells. It may also assist in regulating metabolism, supporting weight reduction, and promoting overall body composition improvements.

Key Benefits:

Supports fat metabolism

May reduce body fat storage

Non-stimulant, non-hormonal approach

Considered safe with a favorable short-term safety profile

While AOD-9604 shows promising results for weight management, it is classified as experimental and investigational. It is not FDA-approved for weight loss or metabolic enhancement. Our program uses AOD-9604 as part of a broader wellness plan, always under the guidance of a licensed provider.

Starts at $117/month

Start your journey!

Fill out the form below to connect with our team.

Welcome to MediDuce Weight Loss & Wellness

Thank you for choosing MediDuce for your wellness journey. Please provide your personal details below to get started. Once you complete the intake form, you will be directed to the payment page, followed by a link to schedule your Telehealth consultation with our provider.

Which program are you interested in?

AOD 9604

AOD 9604 + MOTs-C + Tesamorelin

AOD 9604 + MOTs-C

DISCLOSURE AND CONSENT

Description
AOD-9604 is a synthetic peptide fragment derived from human growth hormone (HGH). It is administered by subcutaneous injection and developed to promote fat metabolism without significantly affecting blood sugar or IGF-1 levels.

Regulatory Status

AOD-9604 is considered experimental and investigational.
It is not FDA-approved for weight loss, metabolic enhancement, or any other indication.

Potential Benefits

May support fat metabolism and body recomposition goals.
May aid in metabolic regulation.

Possible Risks & Side Effects

Injection site irritation
Nausea, headache, or fatigue
Gastrointestinal discomfort
Other unknown risks, as long-term safety data are not available

Fertility & Long-Term Safety

The long-term effects of AOD-9604 are unknown.
Potential impacts on fertility have not been established.

Contraindications / Cautions

Do not use if pregnant or breastfeeding.
Use caution if you have a personal or family history of hormone-sensitive cancers or uncontrolled endocrine disorders.

Patient Acknowledgment

By signing below, I acknowledge and understand that:

AOD-9604 is an investigational, off-label therapy.
Long-term safety—including possible effects on fertility—remains unknown.
I have had the opportunity to discuss risks, benefits, and alternatives with my provider.
I consent to proceed with treatment if medically eligible and recommended.

AOD Program Acknowledgement:

Yes, I consent to AOD-9604 therapy.

No, I decline.

Your prescribed medications will be conveniently shipped to your address by our pharmacy partner, and once they arrive, you’ll be ready to begin your program.

PERSONAL INFORMATION:

First Name *

Last Name *

Date Of Birth *

Phone *

Email *

SHIPPING INFORMATION:

Please double-check all the information you provide regarding your address. This is the address we will use to ship your prescribed medications, so ACCURACY IS A MUST.

Address (Include apartment/unit if applicable) *

City *

Postal code *

State (Please put abbreviation ex: CO, AL, OH) *

HEALTH CONDITIONS & MEDICAL HISTORY

Are you currently pregnant or breastfeeding? *

Yes

No

Are you under 18 years old?

Yes, Pregnant

Yes, Breastfeeding

None of the above

No

What are your primary treatment goals? (Select all that apply) *

Yes

No

Have you experienced any of the following in the past 2 weeks? *

Chronic Fatigue Syndrome (CFS)

Fatigue Management and Health Optimization

Fibromyalgia

General Wellness and Healthy Aging

Healthcare Provider Referral for Treatment

Metabolic Disorders (Type 2 Diabetes, Obesity)

Neurodegenerative Disorders (Alzheimer’s, Parkinson’s, Multiple Sclerosis)

Recovery Support After Illness or Surgery

It is recommended that you obtain baseline lab work including IGF-1, fasting glucose, and thyroid function measured before starting peptide therapy. You are not required to submit labs at this time, but it is your responsibility to obtain them and follow up with your primary care provider if any results are abnormal. Continuing peptide use without confirming normal labs may carry risks. Do you acknowledge this recommendation and accept the risks of proceeding without labs? *

Yes, I acknowledge and accept the risks

No, I do not accept the risks

Are you currently taking any of the following medications? *

If you have any comments, questions, or concerns about your wellness journey, feel free to share them here (optional)

By checking this box I confirm that all information is correct. I agree to terms & conditions provided by the company. By providing my phone number, I agree to receive text messages from the business regarding the program.

Please ensure all information is accurate before proceeding.

Verify Approval for www.mediducewellness.com

(586) 327-5863

[email protected]

Terms of Use - Privacy Policy

(586) 327-5863

[email protected]

Terms of Use - Privacy Policy